IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.

Paci V, Foti R, Pantano I, Carletto A, Celletti E, Miceli GF, Cangemi I, Lopalco G, Montalbano S, Chimenti MS, Picchianti Diamanti A, Massafra U, Filippucci E, Parisi A, Leccese P, Panaccione A, Puca I, Amato G, Marrone S, Di Penta M, Corrao S, Cela E, Rai A, Tirri E, Iannone F, Atzeni F, Rossini M, Ciccia F, Foti R, Moroncini G, Luchetti Gentiloni MM

Open source

DOI
10.1177/1759720x261460108
Published
2026
Container
Therapeutic advances in musculoskeletal disease
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1759720x261460108,
  title = {IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.},
  author = {Paci V and Foti R and Pantano I and Carletto A and Celletti E and Miceli GF and Cangemi I and Lopalco G and Montalbano S and Chimenti MS and Picchianti Diamanti A and Massafra U and Filippucci E and Parisi A and Leccese P and Panaccione A and Puca I and Amato G and Marrone S and Di Penta M and Corrao S and Cela E and Rai A and Tirri E and Iannone F and Atzeni F and Rossini M and Ciccia F and Foti R and Moroncini G and Luchetti Gentiloni MM},
  year = {2026},
  journal = {Therapeutic advances in musculoskeletal disease},
  doi = {10.1177/1759720x261460108},
  url = {https://doi.org/10.1177/1759720x261460108}
}

RIS

TY  - JOUR
TI  - IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.
AU  - Paci V
AU  - Foti R
AU  - Pantano I
AU  - Carletto A
AU  - Celletti E
AU  - Miceli GF
AU  - Cangemi I
AU  - Lopalco G
AU  - Montalbano S
AU  - Chimenti MS
AU  - Picchianti Diamanti A
AU  - Massafra U
AU  - Filippucci E
AU  - Parisi A
AU  - Leccese P
AU  - Panaccione A
AU  - Puca I
AU  - Amato G
AU  - Marrone S
AU  - Di Penta M
AU  - Corrao S
AU  - Cela E
AU  - Rai A
AU  - Tirri E
AU  - Iannone F
AU  - Atzeni F
AU  - Rossini M
AU  - Ciccia F
AU  - Foti R
AU  - Moroncini G
AU  - Luchetti Gentiloni MM
PY  - 2026
JO  - Therapeutic advances in musculoskeletal disease
DO  - 10.1177/1759720x261460108
UR  - https://doi.org/10.1177/1759720x261460108
ER  - 

APA

V, P., R, F., I, P., A, C., E, C., GF, M., I, C., G, L., S, M., MS, C., A, P. D., U, M., E, F., A, P., P, L., A, P., I, P., G, A., S, M., M, D. P., S, C., E, C., A, R., E, T., F, I., F, A., M, R., F, C., R, F., G, M., & MM, L. G. (2026). IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.. Therapeutic advances in musculoskeletal disease. https://doi.org/10.1177/1759720x261460108

Source records